List of Tables
Summary Table: Global Market for Point-of-Care Diagnostics, by Region, Through 2029
Table 1: POCT Alternative Terms
Table 2: Commonly Used POC Devices
Table 3: Recent Tests Approved by the FDA as Waived Tests Under CLIA
Table 4: Estimated Number of People Living with HIV, 2010, 2021 and 2022
Table 5: Number of Hepatitis B Infections (All Ages) in 2022
Table 6: Global Incidences of STIs, 2020 and 2022
Table 7: Projected Number of Adults 50 Years and Older with =1 Chronic Condition in the United States, 2020-2050
Table 8: Number and Proportion of Persons Aged 65 Years and Over, by Development Group, 2023 and 2050
Table 9: Number of Persons Aged 65 Years and Over, by Region, 2019 and 2050
Table 10: Number of Deaths and the Age-Adjusted Death Rate for the 10 Leading Causes of Death in 2022: United States, 2021 and 2022
Table 11: Global Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 12: Global Market for Drug and Alcohol Screening, by Region, Through 2029
Table 13: Global Market for BGEM, by Region, Through 2029
Table 14: Global Market for Cardiac Markers, by Region, Through 2029
Table 15: Global Market for Cholesterol Testing/Monitoring, by Region, Through 2029
Table 16: Global Market for Glucose Testing and Monitoring, by Region, Through 2029
Table 17: Annual Estimated Deaths from HIV/AIDS, Diarrhea, Malaria, Respiratory Infections, and All Other Infectious Diseases in Major Countries, 1980 to 2021
Table 18: Global Market for Infectious Disease Testing, by Region, Through 2029
Table 19: Global Market for Pregnancy and Fertility Testing, by Region, Through 2029
Table 20: Global Market for Hemoglobin and Hemostasis, by Region, Through 2029
Table 21: Examples of Commercially Available POC Devices for Cancer Detection
Table 22: Global Market for Tumor Markers, by Region, Through 2029
Table 23: Some Currently Available Point-of-Care Tests for Proteins in Urine
Table 24: Global Market for Urinalysis/Urine Chemistry, by Region, Through 2029
Table 25: Global Market for Other Types of Point-of-Care Diagnostics Tests, by Region, Through 2029
Table 26: Global Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 27: Global Market for Hardware in Point-of-Care Diagnostics, by Region, Through 2029
Table 28: Global Market for Software in Point-of-Care Diagnostics, by Region, Through 2029
Table 29: Global Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 30: Global Market for Point-of-Care Diagnostics in Hospital and Critical Care End Uses, by Region, Through 2029
Table 31: Global Market for Point-of-Care Diagnostics in Home Care Settings, by Region, Through 2029
Table 32: Global Market for Point-of-Care Diagnostics, by Region, Through 2029
Table 33: North American Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 34: North American Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 35: North American Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 36: North American Market for Point-of-Care Diagnostics, by Country, Through 2029
Table 37: U.S. Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 38: U.S. Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 39: U.S. Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 40: Canadian Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 41: Canadian Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 42: Canadian Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 43: Mexican Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 44: Mexican Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 45: Mexican Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 46: European Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 47: European Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 48: European Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 49: European Market for Point-of-Care Diagnostics, by Country, Through 2029
Table 50: Leading Causes of Disease Burden by DALYs (Level 3)
Table 51: German Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 52: German Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 53: German Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 54: U.K. Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 55: U.K. Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 56: U.K. Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 57: French Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 58: French Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 59: French Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 60: Italian Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 61: Italian Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 62: Italian Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 63: Spanish Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 64: Spanish Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 65: Spanish Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 66: Rest of European Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 67: Rest of European Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 68: Rest of European Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 69: Asia-Pacific Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 70: Asia-Pacific Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 71: Asia-Pacific Market for Point-of-Care Diagnostics, by End User Through 2029
Table 72: Asia-Pacific Market for Point-of-Care Diagnostics, by Country, Through 2029
Table 73: Chinese Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 74: Chinese Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 75: Chinese Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 76: Japanese Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 77: Japanese Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 78: Japanese Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 79: Indian Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 80: Indian Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 81: Indian Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 82: Australian Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 83: Australian Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 84: Australian Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 85: South Korean Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 86: South Korean Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 87: South Korean Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 88: Rest of Asia-Pacific Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 89: Rest of Asia-Pacific Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 90: Rest of Asia-Pacific Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 91: Rest of the World Market for Point-of-Care Diagnostics, by Test Type, Through 2029
Table 92: Rest of the World Market for Point-of-Care Diagnostics, by Product, Through 2029
Table 93: Rest of the World Market for Point-of-Care Diagnostics, by End User, Through 2029
Table 94: Growing Burden of Waste from Diagnostic Devices
Table 95: Emerging and Sustainable Materials for the Fabrication of Single-Use POCT
Table 96: ESG Highlights, by Major Players, 2023
Table 97: ESG Rankings for Point-of-Care Diagnostics Manufacturing Companies, 2023
Table 98: Mergers and Acquisitions: Point-of-Care Diagnostics Market, by Manufacturers, 2021-2024
Table 99: Major Strategic Alliances in the Point-of-Care Diagnostic Industry, 2021-2024
Table 100: FDA Approved Point-of-Care Diagnostics Devices, 2022-2023
Table 101: Patents on on Point-of-Care Diagnostics, by Year, 2021-August 2024
Table 102: Information Sources in this Report
Table 103: Major Abbreviations Used in This Report
Table 104: Abbott: Company Snapshot
Table 105: Abbott: Financial Performance, FY 2022 and 2023
Table 106: Abbott: Product Portfolio
Table 107: Abbott: News/Key Developments, 2021-2024
Table 108: BD: Company Snapshot
Table 109: BD: Financial Performance, FY 2022 and 2023
Table 110: BD: Product Portfolio
Table 111: BD: News/Key Developments, 2022-2023
Table 112: Danaher Corp.: Company Snapshot
Table 113: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 114: Danaher Corp.: Product Portfolio
Table 115: Danaher Corp.: News/Key Developments, 2023 and 2024
Table 116: GE Healthcare: Company Snapshot
Table 117: GE Healthcare: Financial Performance, FY 2022 and 2023
Table 118: GE Healthcare: Product Portfolio
Table 119: GE Healthcare: News/Key Developments, 2023 and 2024
Table 120: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 121: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 122: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 123: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021-2024
Table 124: Medtronic: Company Snapshot
Table 125: Medtronic: Financial Performance, FY 2022 and 2023
Table 126: Medtronic: Product Portfolio
Table 127: Medtronic: News/Key Developments, 2023
Table 128: Quest Diagnostics Inc.: Company Snapshot
Table 129: Quest Diagnostics Inc.: Financial Performance, FY 2022 and 2023
Table 130: Quest Diagnostics Inc.: Product Portfolio
Table 131: Quest Diagnostics Inc.: News/Key Developments, 2021-2024
Table 132: QuidelOrtho Corp.: Company Snapshot
Table 133: QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023
Table 134: QuidelOrtho Corp.: Product Portfolio
Table 135: QuidelOrtho Corp.: News/Key Developments, 2022-2024
Table 136: Siemens Healthineers AG: Company Snapshot
Table 137: Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 138: Siemens Healthineers AG: Product Portfolio
Table 139: Siemens Healthineers AG: News/Key Developments, 2023 and 2024
Table 140: Thermo Fisher Scientific Inc.: Company Snapshot
Table 141: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 142: Thermo Fisher Scientific Inc.: Product Portfolio
Table 143: Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024
List of Figures
Summary Figure: Global Market for Point-of-Care Diagnostics, by Region, 2021-2029
Figure 1: Global Market Dynamics of Point-of-Care Diagnostics
Figure 2: Malaria-Endemic Countries, 2022
Figure 3: Top 10 Common Chronic Conditions in Adults 65+, U.S., 2024
Figure 4: Annual Investment in STI Research Needs of People in Low<li>and Middle-Income Countries, 2018-2022
Figure 5: Global Market Shares of Point-of-Care Diagnostics, by Test Type, 2023
Figure 6: Share of New Cancer Cases Globally, by Region, 2022
Figure 7: Share of Cancer Mortality Cases Globally, by Region, 2022
Figure 8: Global Market Shares of Point-of-Care Diagnostics, by Product, 2023
Figure 9: Global Market Shares of Point-of-Care Diagnostics, by End User, 2023
Figure 10: COVID-19 Diagnostic Possibilities, Sampling, and Turnaround Time
Figure 11: Global Market Shares of Point-of-Care Diagnostics, by Region, 2023
Figure 12: North American Market Shares in Point-of-Care Diagnostics, by Country, 2023
Figure 13: Limitations of Using POC Devices in India
Figure 14: Overview of the POCT Life Cycle Associated with Environmental Burdens and Sustainable Solutions for Each Stage
Figure 15: Share of Patents Published on Point-of-Care Diagnostics, by Country, 2021-2024
Figure 16: Global Market Shares of Point-of-Care Diagnostics, by Manufacturer/Supplier, 2023
Figure 17: Abbott: Revenue Share, by Country/Region, FY 2023
Figure 18: Abbott: Revenue Share, by Business Unit, FY 2023
Figure 19: BD: Revenue Share, by Country/Region, FY 2023
Figure 20: BD: Revenue Share, by Business Unit, FY 2023
Figure 21: Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 22: Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 23: GE Healthcare: Revenue Share, by Business Unit, FY 2023
Figure 24: GE Healthcare: Revenue Share, by Country/Region, FY 2023
Figure 25: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 26: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 27: Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 28: Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 29: Quest Diagnostics Inc.: Revenue Share, by Business Unit, FY 2023
Figure 30: QuidelOrtho Corp.: Revenue Share, by Business Unit, FY 2023
Figure 31: QuidelOrtho Corp.: Revenue Share, by Country/Region, FY 2023
Figure 32: Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2023
Figure 33: Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2023
Figure 34: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35: Thermo Fisher Scientific Inc.: Revenue Share, by Region, FY 2023